Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ribrag

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 22, 2019
Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?J M Michot, J Lazarovici, A Tieu, et al.
Cancer Research|July 15, 1992
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasmsI Marcillac, F Troalen, J M Bidart, et al.
Leukemia & Lymphoma|March 4, 2024
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 studyC Quivoron, J-M Michot, A Danu, et al.
Leukemia & Lymphoma|July 16, 2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationE Jabbour, N Peslin, P Arnaud, et al.
Biochemistry. Biokhimiia|April 9, 2018
Effect of Environmental Factors on Nuclear Organization and Transformation of Human B LymphocytesF B Sall, D Germini, A P Kovina, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patientsR M'kacher, T Girinsky, S Koscielny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocolM Diviné, P Casassus, S Koscielny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysisR Bouabdallah, N Mounier, C Guettier, et al.
British Journal of Haematology|February 1, 1996
Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantationA Buzyn-Veil, C Belanger, F Audat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphomaC Soussain, F Suzan, K Hoang-Xuan, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|October 22, 2019
Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?J M Michot, J Lazarovici, A Tieu, et al.
Cancer Research|July 15, 1992
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasmsI Marcillac, F Troalen, J M Bidart, et al.
Leukemia & Lymphoma|March 4, 2024
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 studyC Quivoron, J-M Michot, A Danu, et al.
Leukemia & Lymphoma|July 16, 2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationE Jabbour, N Peslin, P Arnaud, et al.
Biochemistry. Biokhimiia|April 9, 2018
Effect of Environmental Factors on Nuclear Organization and Transformation of Human B LymphocytesF B Sall, D Germini, A P Kovina, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patientsR M'kacher, T Girinsky, S Koscielny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocolM Diviné, P Casassus, S Koscielny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysisR Bouabdallah, N Mounier, C Guettier, et al.
British Journal of Haematology|February 1, 1996
Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantationA Buzyn-Veil, C Belanger, F Audat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphomaC Soussain, F Suzan, K Hoang-Xuan, et al.
Pageof 10